Invizyne

Monrovia, United States Founded: 2014 • Age: 12 yrs
Enzymatic bioconversions are designed for cannabinoid product synthesis.
Annual revenue - Latest available
Total funding - 5 rounds
Employees 16 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Invizyne

Invizyne is a company based in Monrovia (United States) founded in 2014 by Paul Opgenorth, Tyler Korman, and James Bowie. The company has 16 employees as of December 31, 2022.

  • Headquarter Monrovia, United States
  • Employees 16 as on 31 Dec, 2022
  • Founders Paul Opgenorth, Tyler Korman, James Bowie
  • Stage Public
  • Sectors
    Consumer
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Consumer → Tobacco, Cannabis & Alternative Products Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $243.53 K (USD), Grant

    Feb 01, 2024

  • Investors
  • Employee Count
    16

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Invizyne

Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Tyler Korman
Chief Scientific Officer
People
John Billingsley
Director
People
Zachary Karl
Vice President, Head Of Business Development
People
Michael Heltzen
Chief Executive Officer

Unlock access to complete

Funding Insights of Invizyne

Investors in Invizyne

Invizyne has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include OSTI.GOV.

All
Institutional
Investor Description Founded Year Domain Location
Scientific and technical information is managed and disseminated by OSTI.GOV.
Locked Locked Locked
Premium access

Investor details for Invizyne

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Invizyne

Investments
Premium access

Investment portfolio details for Invizyne

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Invizyne

Premium access

Detailed financials for Invizyne

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Invizyne Comparisons

Invizyne Primary company
Description
Enzymatic bioconversions are designed for cannabinoid produc...
Location
Monrovia, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
16
As of 2022
Premium access

Peer comparison for Invizyne

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Invizyne

Premium access

Detailed competitors of Invizyne

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Invizyne

Premium access

Complete news archive for Invizyne

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Invizyne

Invizyne was founded in 2014 and raised its 1st funding round 5 years after it was founded.

Invizyne is headquartered in Monrovia, United States. It is registered at Monrovia, California, United States.

Mo Hayat is the current CEO of Invizyne.

As of Dec 31, 2022, the latest employee count at Invizyne is 16.

Invizyne was founded in 2014 in Monrovia, United States. Enzymatic bioconversions are engineered by the company to synthesize cannabinoid products within the biotechnology sector. Synthetic biology methods are employed to facilitate efficient production processes. Operations are based in the United States, with focus on bioconversion technologies. Leadership is provided by CEO Mo Hayat, alongside co-founders Paul Opgenorth, Tyler Korman, and James Bowie.

Invizyne has 1 investor. Key investors include OSTI.GOV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available